The Effect of Prophylaxis with Low Dose Heparin on Blood Coagulation Parameters

Summary

Heparin was administered subcutaneously 5.000 IU twice daily using a double blind method to ten of twenty-one patients undergoing transvesical prostatectomy.

Platelet count, APTT, thrombin time, Reptilase time, Normotest, fibrinogen, Factor- VIII, ethanol gelation test, antithrombin III, fibrinolytic degradation products, α¹-antitrypsin and α²-macroglobulin were studied pre- and postoperatively up to the 10th postoperative day. Statistical analysis of parameters of blood coagulation and fibrinolysis showed no significant difference between the two groups. The mechanism by which low dose heparin exerts its thromboprophylactic effect could not be elucidated from the study of the investigated parameters. The laboratory data gave no indication to a possible increased risk of postoperative hemorrhage.

• References

• 1 Abildgaard U, Gravem K, Godal HC. 1970; Assay of progressive antithrombin in plasma. Thrombosis et Diathesis Haemorrhagica 24: 224
• 2 Abildgaard U, Lie M, ØDegård OR. 1976; A simple method for the determination of functionally active antithrombin III. Scandinavian Journal of Clinical and Laboratory Investigations 36: 109
• 3 Fagerhol MK, Abildgaard U. 1970; Immunological studies on human antithrombin III. Scandinavian Journal of Haematology 7: 10
• 4 Kakkar VV, Corrigan TP, Fossard DP, Sutherland I, Shelton MG, Thirwall J. 1975; Prevention of fatal postoperative pulmonary embolism by low doses of heparin. The Lancet July 12 45
• 5 Kakkar VV, Field ES, Nicolaides AN, Flute PT, Wessler S, Yin ET. 1971; Low doses of heparin in prevention of deep-vein thrombosis. The Lancet Sept. 15 669
• 6 Kierulf P, Godal HC. 1971; Fibrinemia in medical patients screened by the ethanol test. Acta Medica Scandinavica 190: 185
• 7 Kristenson A. 1922; A new method for the direct counting of the so-called blood platelets in man. Acta Medica Scandinavica 57: 301
• 8 LANCET. 1974 Subcutaneous heparin. Leading article The Lancet August 31
• 9 Latallo ZS, Wegrzynowicz Z, Teisseyre E, Kopec M. 1971; Simple and rapid evaluation of the intravascular coagulation and fibrinolytic states by application of protamine sulphate and Reptilase R. Scandinavian Journal of Haematology 13: 387
• 10 Laurell CB. 1966; Quantitative estimations of proteins by electrophoresis in agarose gel containing antibodies. Analytical Biochemistry 15: 45
• 11 Mancini G, Carbonara AO, Heremans JF. 1965; Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235
• 12 Mcwilliam R, Mccormick ST JC, Aulaqi A. 1974 Bleeding and perioperative heparin. The Lancet. August 3
• 13 Noren I. 1972; Clinical application of a new assay of factor VIII and factor VIII inhibitors. Thrombosis Research 1: 19
• 14 Noren I, Blomback M. 1971; A quick method for the assay of factor VIII with use of standardized reagents in a thrombin generation system. Coagulation 4: 119
• 15 Nyman D. 1973; Aktiverad partiell tromboplastintid vid diagnostik av koagulationsrubbningar. Läkartidningen 70: 3241
• 16 ØDegård OR, Lie M, Abildgaard U. 1975; Heparin cofactor activity measured with an amidolytic method. Thrombosis Research 6: 287
• 17 Owren PA, Strandli OK. 1969; Normotest. Farmakoterapi 1-2 14
• 18 Pitcher PM. 1971; Preparation of a rapid slide test for the detection of fibrinogen degradation products (FDP) in serum and a preliminary report on its use as a clinical screening test. 2nd Congress of the International Society of Thrombosis and Haemostasis, Oslo, abstr 282
• 19 Proctor RR, Rapaport SI. 1961; The partial thromboplastin time with kaolin. American Journal of Clinical Pathology 36: 212
• 20 Vermylen C, De Vreeker RA, Verstraete M. 1963; A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). Clinica Chimica Acta 8: 418
• 21 Yin ET, Wessler S, Stoll PJ. 1970; Biological properties of the naturally occurring plasma inhibitor of activated factor X. Journal of Biological Chemistry 246: 3703